Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters

Fig. 3

Overall survival analysed by grouping patients above and below the median for (a) BDCA-2+ DC % of total PBMC at baseline, and (b) BDCA-3+ DC % of total PBMC at cycle 2 day 8 or cycle 3 day 8. Statistical significance calculated using Mantel Cox log rank test. Solid and dotted lines show data above and below the median values, respectively

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us